Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F5ZJF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,365
Award facts
- Contract value 100% obligated
- $6,365.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,365.41 to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant used primarily in the treatment of rheumatoid arthritis and other autoimmune conditions, representing a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. The parent contract enables the company to supply an extensive range of brand-name and generic medications, biologics, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp demonstrates significant capability in fulfilling specialized healthcare commodity needs through open competition and maintains a substantial portfolio of federal medical supply contracts.
Quick answers
Who was awarded contract SPE2DR26F5ZJF?
SPE2DR26F5ZJF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F5ZJF worth?
The government has obligated $6,365 on SPE2DR26F5ZJF.
Is contract SPE2DR26F5ZJF an order under another contract?
Yes. SPE2DR26F5ZJF is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZJF competed?
The extent of competition for SPE2DR26F5ZJF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award